News
Synairgen plc - Grant of Options
RNS Number: 1396 K Synairgen plc 06 April 2018 Press Release. Southampton, UK- 6 April 2018: Synairgen plc, the respiratory drug discovery and development company, announces that o n 5 April 2018 the Board of Synairgen granted options over 2,822,316 ordinary shares of one pence each in the capital of the Company at an exercise price of one pence per Ordinary Share.
RNS Number: 1396 K Synairgen plc 06 April 2018 Press Release. Southampton, UK- 6 April 2018: Synairgen plc, the respiratory drug discovery and development company, announces that o n 5 April 2018 the Board of Synairgen granted options over 2,822,316 ordinary shares of one pence each in the capital of the Company at an exercise price of one pence per Ordinary Share.